Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Spero Therapeutics (SPRO) - Cash on Hand
Cash on Hand as of December 2023 : $76.33 M
According to Spero Therapeutics's latest financial reports the company has $76.33 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Spero Therapeutics - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $76.33 M | -30.04% |
| 2022-12-31 | $0.10 B | -25.47% |
| 2021-12-31 | $0.14 B | 15.36% |
| 2020-12-31 | $0.12 B | 54.68% |
| 2019-12-31 | $82.04 M | -28.93% |
| 2018-12-31 | $0.11 B | 32.26% |
| 2017-12-31 | $87.28 M | 746.22% |
| 2016-12-31 | $10.31 M | 81.25% |
| 2015-12-31 | $5.69 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 IBM IBM | $13.44 B | 17,508.37% | 🇺🇸 USA |
 Thomson Reuters
TRI | $1.26 B | 1,555.90% | 🇨🇦 Canada |
 Franklin Covey FC | $40.9 M | -46.41% | 🇺🇸 USA |